表紙:ユーバイオティクスの世界市場 - 市場規模(製品別、形態別、用途別、家畜別)、地域の見通し、成長可能性、価格動向、競合の市場シェア、予測(2023年~2032年)
市場調査レポート
商品コード
1228329

ユーバイオティクスの世界市場 - 市場規模(製品別、形態別、用途別、家畜別)、地域の見通し、成長可能性、価格動向、競合の市場シェア、予測(2023年~2032年)

Eubiotics Market Size By Product, By Form, By Application, By Livestock, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2032

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 434 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
ユーバイオティクスの世界市場 - 市場規模(製品別、形態別、用途別、家畜別)、地域の見通し、成長可能性、価格動向、競合の市場シェア、予測(2023年~2032年)
出版日: 2023年02月21日
発行: Global Market Insights Inc.
ページ情報: 英文 434 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のユーバイオティクス市場は、人間と動物の健康や福祉についての意識の高まりにより、2023年~2032年に大きな成長を示すと予測されています。

当レポートでは、世界のユーバイオティクス市場について調査分析し、業界の考察、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ユーバイオティクス業界の考察

  • 業界セグメンテーション
  • 業界情勢(2018年~2032年)
  • 業界エコシステム分析
    • ベンダーマトリックス
    • 流通チャネル分析
    • サプライチェーンと原材料調達に対するCOVID-19の影響
  • 規制情勢
    • 米国
    • カナダ
    • 欧州
    • 中国
  • 価格分析、COVID-19の影響
    • 料金:地域別
    • コスト構造分析
  • 技術情勢
    • プロバイオティクスの製造工程
    • プレバイオティクスの製造工程
    • エッセンシャルオイル技術の情勢
    • 有機酸技術の情勢
    • 酵素剤
  • 比較
    • プレバイオティクス vs. プロバイオティクス
  • 業界に対する影響要因
    • 成長促進要因
    • 業界の潜在的リスク・課題
  • 革新と持続可能性
    • 持続可能な化学のための生体触媒
    • DNA診断
  • 成長可能性分析(2022年)
    • 新たなビジネスモデル
  • ポーターのファイブフォース分析
  • 競合情勢(2019年)
    • 企業の市場シェア分析(2022年)
    • 戦略ダッシュボード
  • PESTEL分析
  • ユーバイオティクス市場に対するCOVID-19の影響:用途別
    • 動物飼料
  • 世界経済に対するCOVID-19の影響の概要
    • 消費者の購買行動に対するCOVID-19の影響
  • ユーバイオティクス市場の主な成功要因
    • 顧客のアンメットニーズ
    • 効率的な流通チャネル/サプライチェーン
    • マーケティングの課題
    • キャッシュフローの保護と流動性
    • 製品の浸透価格
    • イノベーションの課題

第4章 競合情勢(2022年)

  • イントロダクション
  • 企業の市場シェア(2022年)
  • 主要市場企業の競合の分析
  • 競合ポジショニングマトリックス
  • 戦略的見通しマトリックス

第5章 ユーバイオティクス市場:製品別

  • 主な製品の動向
  • プレバイオティクス
  • プロバイオティクス
  • 有機酸
  • エッセンシャルオイル
  • 酵素剤

第6章 ユーバイオティクス市場:形態別

  • 主な形態の動向
  • 乾燥
  • 液体

第7章 ユーバイオティクス市場:用途別

  • 主な用途の動向
  • 腸の健康
  • 生産
  • 免疫
  • その他

第8章 ユーバイオティクス市場:家畜別

  • 主な家畜の動向
  • 家禽
  • 水産養殖
  • その他

第9章 ユーバイオティクス市場:地域別

  • 主な地域の動向
  • 北米
    • 北米のユーバイオティクス市場(2018年~2032年)
    • 北米のユーバイオティクス市場:製品別(2018年~2032年)
    • 北米のユーバイオティクス市場:形態別(2018年~2032年)
    • 北米のユーバイオティクス市場:用途別(2018年~2032年)
    • 北米のユーバイオティクス市場:家畜別(2018年~2032年)
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州のユーバイオティクス市場(2018年~2032年)
    • 欧州のユーバイオティクス市場:製品別(2018年~2032年)
    • 欧州のユービオティックス市場:形態別(2018年~2032年)
    • 欧州のユーバイオティクス市場:用途別(2018年~2032年)
    • 欧州のユーバイオティクス市場:家畜別(2018年~2032年)
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • ロシア
    • スペイン
  • アジア太平洋
    • アジア太平洋のユーバイオティクス市場(2018年~2032年)
    • アジア太平洋のユーバイオティクス市場:製品別(2018年~2032年)
    • アジア太平洋のユーバイオティクス市場:形態別(2018年~2032年)
    • アジア太平洋のユーバイオティクス市場:用途別(2018年~2032年)
    • アジア太平洋のユーバイオティクス市場:家畜別(2018年~2032年)
    • 中国
    • インド
    • 日本
    • タイ
    • マレーシア
    • オーストラリア
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカのユーバイオティクス市場(2018年~2032年)
    • ラテンアメリカのユーバイオティクス市場:製品別(2018年~2032年)
    • ラテンアメリカのユーバイオティクス市場:形態別(2018年~2032年)
    • ラテンアメリカのユーバイオティクス市場:用途別(2018年~2032年)
    • ラテンアメリカのユーバイオティクス市場:家畜別(2018年~2032年)
    • ブラジル
  • 中東・アフリカ
    • 中東・アフリカのユーバイオティクス市場(2018年~2032年)
    • 中東・アフリカのユーバイオティクス市場:製品別(2018年~2032年)
    • 中東・アフリカのユーバイオティクス市場:形態別(2018年~2032年)
    • 中東・アフリカのユーバイオティクス市場:用途別(2018年~2032年)
    • 中東・アフリカのユーバイオティクス市場:家畜別(2018年~2032年)
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第10章 企業プロファイル

  • DSM
  • Novus International
  • BASF SE
  • Beneo GmbH
  • Cargill, Inc.
  • ROQUETTE Freres
  • Novozymes
  • Calpis Co., Ltd.
  • Lesaffre Group
  • Behn Meyer
  • Lallemand, Inc.
  • Friesland Campina
  • Chr. Hansen Holding A/S
  • Neospark
  • Kemin Industries, Inc.
  • BioResource International Inc
  • ABVista
  • Alltech
目次
Product Code: 457

Eubiotics Market is anticipated to depict strong growth during 2023-2032 owing to the increasing awareness regarding physical health and welfare of humans and animals. Eubiotics, including probiotics, prebiotics, organic acids, and essential oils, are used mainly to improve the health status and boost the immunity of domesticated animals. The product's efficacy depends on its antimicrobial effects and ability to alter gut flora.

Eubiotics are gaining strong traction in developed countries as they help improve the immune system. Besides, they also promote healthy digestion and serve as an alternative to antibiotics in feed. Eubiotic meal supplements have attracted massive attention in human and animal feed additives due to the increased need for securing human food worldwide and the development of environmentally friendly animal and fishery feed products.

Overall, the eubiotics industry is segmented in terms of form, application, livestock, product, and region.

Based on form, the liquid form segment is anticipated to grow considerably during the estimated timeframe. Liquid eubiotics help enhance dairy calves' health, performance, ruminal fermentation, and biochemical blood indicators during the preweaning stage, when added to the milk replacer.

By application, the yield segment will depict 7% CAGR through 2032, as eubiotics are feed additives that support animal performance and welfare by supporting gut health. Besides, advantages such as reducing the need for antibiotics, ensuring efficient use of natural resources, cutting the environmental footprint of farms, and improving farmer incomes will assist the segmental growth in the future.

Considering the livestock, the poultry segment is expected to be valued at over USD 885 million by 2032. Increasing per-capita meat consumption and rising livestock production will boost the product demand for poultry. As per reports, the global meat consumption is estimated to reach between 460 million and 570 million tons by 2050. Besides, the rising demand for protein-rich diets and nutritious food will also play a key role in expanding the segment valuation.

In terms of product, the prebiotics segment will most likely register noticeable gains over the next decade. Prebiotics are given to animals to maintain the beneficial microflora by regulating the harmful microbial activity. They are also used as therapeutic supplements in farm animals to decrease morbidity and mortality, improve feeding behavior, and increase production (meat, milk, and eggs) yield.

Regionally, the Asia Pacific eubiotics market is expected to register notable gains through 2032. Increasing consumption of derived products and growing influence on animal health in the region will drive the industry outlook. Besides, the technological advancements coupled with the increasing adoption of sustainable farming techniques will also positively influence market expansion.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates & working
    • 1.2.1 Forecast calculations
  • 1.3 Data Sources
    • 1.3.1 Primary
    • 1.3.2 Secondary
      • 1.3.2.1 Paid Sources
      • 1.3.2.2 Public Sources

Chapter 2 Executive Summary

  • 2.1 Eubiotics industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business Trends
    • 2.1.2 Regional Trends
    • 2.1.3 Product Trends
    • 2.1.4 Form Trends
    • 2.1.5 Livestock Trends
    • 2.1.6 Application Trends

Chapter 3 Eubiotics Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032
  • 3.3 Industry ecosystem analysis
    • 3.3.1 Vendor matrix
    • 3.3.2 Distribution channel analysis
      • 3.3.2.1 Collaboration/Partnerships
      • 3.3.2.2 Service Providers
      • 3.3.2.3 Contract Manufacturing
      • 3.3.2.4 Technology Providers
    • 3.3.3 Impact of COVID-19 on supply chain & raw material procurement
  • 3.4 Regulatory landscape
    • 3.4.1 U.S.
    • 3.4.2 Canada
    • 3.4.3 Europe
    • 3.4.4 China
  • 3.5 Pricing analysis, COVID-19 Impact
    • 3.5.1 Regional pricing
      • 3.5.1.1 Prebiotic pricing analysis
      • 3.5.1.2 Probiotics pricing analysis
      • 3.5.1.3 Organic acids pricing analysis
      • 3.5.1.4 Essential oil pricing analysis
      • 3.5.1.5 Exogeneous enzymes pricing analysis
    • 3.5.2 Cost structure analysis
  • 3.6 Technology landscape
    • 3.6.1 Probiotic manufacturing process
    • 3.6.2 Prebiotic manufacturing process
    • 3.6.3 Essential Oil Technology Landscape
    • 3.6.4 Organic Acid Technological Landscape
    • 3.6.5 Exogeneous enzymes
      • 3.6.5.1 Multi enzyme combination of amylase, protease and xylanase to improve performance in gut health
      • 3.6.5.2 Gut microbiota balance - DuPont Study
      • 3.6.5.3 Biotechnology application in improving livestock productivity
      • 3.6.5.4 Alterion Technology
      • 3.6.5.5 Effects of Bacillus subtilis strains on immunity, performance and livestock gut health
      • 3.6.5.6 Multi - Carbohydrate technology delivering higher nutritional extraction from wide arena of animal feed products
  • 3.7 Comparison
    • 3.7.1 Prebiotics vs Probiotics
  • 3.8 Industry impact forces
    • 3.8.1 Growth drivers
      • 3.8.1.1 Increases consumption of meat in Asia Pacific
      • 3.8.1.2 Antibiotics ban in Europe and U.S.
      • 3.8.1.3 Emerging livestock diseases
    • 3.8.2 Industry pitfalls & challenges
      • 3.8.2.1 Standardization issue
      • 3.8.2.2 Lack of systematic evaluation
  • 3.9 Innovation & sustainability
    • 3.9.1 Bio-catalysis for sustainable chemistry
    • 3.9.2 DNA diagnostics
  • 3.10 Growth potential analysis, 2022
    • 3.10.1 Emerging business model
      • 3.10.1.1 Collaboration/Joint ventures
      • 3.10.1.2 Acquisitions
      • 3.10.1.3 New product launches
  • 3.11 Porter's analysis
    • 3.11.1 Bargaining power of suppliers
    • 3.11.2 Bargaining power of buyers
    • 3.11.3 Threat of new entrants
    • 3.11.4 Threat of substitutes
  • 3.12 Competitive landscape, 2019
    • 3.12.1 Company Market share analysis, 2022
    • 3.12.2 Strategic dashboard
  • 3.13 PESTEL analysis
  • 3.14 COVID-19 impact on eubiotics market, by application
    • 3.14.1 Animal feed
      • 3.14.1.1 Poultry
      • 3.14.1.2 Swine
      • 3.14.1.3 Cattle
      • 3.14.1.4 Aquaculture
      • 3.14.1.5 Others
  • 3.15 Overview of COVID-19 impact on world economy
    • 3.15.1 COVID-19 impact on consumer buying behaviour
      • 3.15.1.1 Proactive health-minded buying
      • 3.15.1.2 Reactive health management
      • 3.15.1.3 Pantry preparation
      • 3.15.1.4 Quarantined living preparation
      • 3.15.1.5 Novel shopping practice
  • 3.16 Key success factors of the eubiotics market
    • 3.16.1 Unmet customer needs
      • 3.16.1.1 Continuous demand fulfilment (B2B)
      • 3.16.1.2 Quality & efficacy
    • 3.16.2 Efficient distribution channel/supply chain
      • 3.16.2.1 Distribution of ingredients/products to the end-use manufacturers/consumers
    • 3.16.3 Marketing challenges
    • 3.16.4 Cash flow protection & liquidity
      • 3.16.4.1 Short term financial obligations
      • 3.16.4.2 Long term financial obligations
    • 3.16.5 Product penetration pricing
    • 3.16.6 Innovation challenges

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company market share, 2022
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic outlook matrix

Chapter 5 Eubiotics Market, By Product

  • 5.1 Key product trends
  • 5.2 Prebiotics
    • 5.2.1 Global prebiotics market, 2018 - 2032
    • 5.2.2 Global prebiotics market, by region, 2018 - 2032
    • 5.2.3 Global prebiotics market, by ingredients, 2018 - 2032
      • 5.2.3.1 Inulin
        • 5.2.3.1.1 Global inulin market, 2018 - 2032
        • 5.2.3.1.2 Global inulin market, by region, 2018 - 2032
      • 5.2.3.2 Fructo-Oligosaccharide (FOS)
        • 5.2.3.2.1 Global FOS market, 2018 - 2032
        • 5.2.3.2.2 Global FOS market, by region, 2018 - 2032
      • 5.2.3.3 Mannan-Oligosaccharide (MOS)
        • 5.2.3.3.1 Global MOS market, 2018 - 2032
        • 5.2.3.3.2 Global FOS market, by region, 2018 - 2032
      • 5.2.3.4 Galacto-Oligosaccharide (GOS)
        • 5.2.3.4.1 Global GOS market, 2018 - 2032
        • 5.2.3.4.2 Global GOS market, by region, 2018 - 2032
      • 5.2.3.5 Others
        • 5.2.3.5.1 Global other prebiotic ingredients market, 2018 - 2032
        • 5.2.3.5.2 Global other prebiotic ingredients market, by region, 2018 - 2032
  • 5.3 Probiotics
    • 5.3.1 Global probiotics market, 2018 - 2032
    • 5.3.2 Global probiotics market, by region, 2018 - 2032
    • 5.3.3 Global probiotics market, by ingredients, 2018 - 2032
      • 5.3.3.1 Lactobacillus
        • 5.3.3.1.1 Global lactobacillus market, 2018 - 2032
        • 5.3.3.1.2 Global lactobacillus market, by region, 2018 - 2032
      • 5.3.3.2 Bifidobacterium
        • 5.3.3.2.1 Global bifidobacterium market, 2018 - 2032
        • 5.3.3.2.2 Global bifidobacterium market, by region, 2018 - 2032
      • 5.3.3.3 Bacillus
        • 5.3.3.3.1 Global bacillus market, 2018 - 2032
        • 5.3.3.3.2 Global bacillus market, by region, 2018 - 2032
      • 5.3.3.4 Streptococcus
        • 5.3.3.4.1 Global streptococcus market, 2018 - 2032
        • 5.3.3.4.2 Global streptococcus market, by region, 2018 - 2032
      • 5.3.3.5 Others
        • 5.3.3.5.1 Global other probiotic ingredients market, 2018 - 2032
        • 5.3.3.5.2 Global other probiotic ingredients market, by region, 2018 - 2032
  • 5.4 Organic acids
    • 5.4.1 Global organic acids market, 2018 - 2032
    • 5.4.2 Global organic acids market, by region, 2018 - 2032
    • 5.4.3 Global organic acids market, by product, 2018 - 2032
      • 5.4.3.1 Acetic acid
        • 5.4.3.1.1 Global acetic acid market, 2018 - 2032
        • 5.4.3.1.2 Global acetic acid market, by region, 2018 - 2032
      • 5.4.3.2 Lactic acid
        • 5.4.3.2.1 Global lactic acid market, 2018 - 2032
        • 5.4.3.2.2 Global lactic acid market, by region, 2018 - 2032
      • 5.4.3.3 Fumaric acid
        • 5.4.3.3.1 Global fumaric acid market, 2018 - 2032
        • 5.4.3.3.2 Global fumaric acid market, by region, 2018 - 2032
      • 5.4.3.4 Formic acid
        • 5.4.3.4.1 Global formic acid market, 2018 - 2032
        • 5.4.3.4.2 Global formic acid market, by region, 2018 - 2032
      • 5.4.3.5 Propionic acid
        • 5.4.3.5.1 Global propionic acid market, 2018 - 2032
        • 5.4.3.5.2 Global propionic acid market, by region, 2018 - 2032
      • 5.4.3.6 Others
        • 5.4.3.6.1 Global other organic acids acid market, 2018 - 2032
        • 5.4.3.6.2 Global other organic acids acid market, by region, 2018 - 2032
  • 5.5 Essential oils
    • 5.5.1 Global essential oils market, 2018 - 2032 (Kilo Tons) (USD Million)
    • 5.5.2 Global essential oils market, by region, 2018 - 2032 (Kilo Tons) (USD Million)
  • 5.6 Exogeneous enzymes
    • 5.6.1 Global exogeneous enzymes market, 2018 - 2032
    • 5.6.2 Global exogeneous enzymes market, by region, 2018 - 2032
    • 5.6.3 Global exogeneous enzymes market, by product, 2018 - 2032
      • 5.6.3.1 Amylase
        • 5.6.3.1.1 Global amylase market, 2018 - 2032
        • 5.6.3.1.2 Global amylase market, by region, 2018 - 2032
      • 5.6.3.2 Protease
        • 5.6.3.2.1 Global protease market, 2018 - 2032
        • 5.6.3.2.2 Global protease market, by region, 2018 - 2032
      • 5.6.3.3 Phytase
        • 5.6.3.3.1 Global phytase market, 2018 - 2032
        • 5.6.3.3.2 Global phytase market, by region, 2018 - 2032
      • 5.6.3.4 Xylanases
        • 5.6.3.4.1 Global xylanases market, 2018 - 2032
        • 5.6.3.4.2 Global xylanases market, by region, 2018 - 2032
      • 5.6.3.5 B-glucanase
        • 5.6.3.5.1 Global B-glucanase market, 2018 - 2032
        • 5.6.3.5.2 Global B-glucanase market, by region, 2018 - 2032

Chapter 6 Eubiotics Market, By Form

  • 6.1 Key form trends
  • 6.2 Dry form
    • 6.2.1 Global dry form eubiotics market, 2018 - 2032 (Kilo Tons) (USD Million)
    • 6.2.2 Global dry form eubiotics market, by region, 2018 - 2032 (Kilo Tons) (USD Million)
  • 6.3 Liquid form
    • 6.3.1 Global liquid form eubiotics market, 2018 - 2032 (Kilo Tons) (USD Million)
    • 6.3.2 Global liquid form eubiotics market, by region, 2018 - 2032 (Kilo Tons) (USD Million)

Chapter 7 Eubiotics Market, By Application

  • 7.1 Key application trends
  • 7.2 Gut health
    • 7.2.1 Global eubiotics market from gut health, 2018 - 2032, (Kilo Tons) (USD Million)
    • 7.2.2 Global eubiotics market from gut health, by region, 2018 - 2032 (Kilo Tons) (USD Million)
  • 7.3 Yield
    • 7.3.1 Global eubiotics market from yield, 2018 - 2032, (Kilo Tons) (USD Million)
    • 7.3.2 Global eubiotics market from yield, by region, 2018 - 2032 (Kilo Tons) (USD Million)
  • 7.4 Immunity
    • 7.4.1 Global eubiotics market from immunity, 2018 - 2032, (Kilo Tons) (USD Million)
    • 7.4.2 Global eubiotics market from immunity, by region, 2018 - 2032 (Kilo Tons) (USD Million)
  • 7.5 Others
    • 7.5.1 Global eubiotics market from other applications, 2018 - 2032, (Kilo Tons) (USD Million)
    • 7.5.2 Global eubiotics market from other applications, by region, 2018 - 2032 (Kilo Tons) (USD Million)

Chapter 8 Eubiotics Market, By Livestock

  • 8.1 Key livestock trends
  • 8.2 Poultry
    • 8.2.1 Global eubiotics market from poultry, 2018 - 2032, (Kilo Tons) (USD Million)
    • 8.2.2 Global eubiotics market from poultry, by region, 2018 - 2032, (Kilo Tons) (USD Million)
  • 8.3 Swine
    • 8.3.1 Global eubiotics market from swine, 2018 - 2032, (Kilo Tons) (USD Million)
    • 8.3.2 Global eubiotics market from swine, by region, 2018 - 2032, (Kilo Tons) (USD Million)
  • 8.4 Cattle
    • 8.4.1 Global eubiotics market from cattle, 2018 - 2032, (Kilo Tons) (USD Million)
    • 8.4.2 Global eubiotics market from cattle, by region, 2018 - 2032, (Kilo Tons) (USD Million)
  • 8.5 Aquaculture
    • 8.5.1 Global eubiotics market from aquaculture, 2018 - 2032, (Kilo Tons) (USD Million)
    • 8.5.2 Global eubiotics market from aquaculture, by region, 2018 - 2032, (Kilo Tons) (USD Million)
  • 8.6 Other
    • 8.6.1 Global eubiotics market from other livestock, 2018 - 2032, (Kilo Tons) (USD Million)
    • 8.6.2 Global eubiotics market from other livestock, by region, 2018 - 2032, (Kilo Tons) (USD Million)

Chapter 9 Eubiotics Market, By Region

  • 9.1 Key regional trends
  • 9.2 North America
    • 9.2.1 North America eubiotics market, 2018 - 2032
    • 9.2.2 North America eubiotics market, by product, 2018 - 2032
    • 9.2.3 North America eubiotics market, by form, 2018 - 2032
    • 9.2.4 North America eubiotics market, by application, 2018 - 2032
    • 9.2.5 North America eubiotics market, by livestock, 2018 - 2032
    • 9.2.6 U.S.
      • 9.2.6.1 U.S. eubiotics market, 2018 - 2032
      • 9.2.6.2 U.S. eubiotics market, by product, 2018 - 2032
      • 9.2.6.3 U.S. eubiotics market, by form, 2018 - 2032
      • 9.2.6.4 U.S. eubiotics market, by application, 2018 - 2032
      • 9.2.6.5 U.S. eubiotics market, by livestock, 2018 - 2032
    • 9.2.7 Canada
      • 9.2.7.1 Canada eubiotics market, 2018 - 2032
      • 9.2.7.2 Canada eubiotics market, by product, 2018 - 2032
      • 9.2.7.3 Canada eubiotics market, by form, 2018 - 2032
      • 9.2.7.4 Canada eubiotics market, by application, 2018 - 2032
      • 9.2.7.5 Canada eubiotics market, by livestock, 2018 - 2032
    • 9.2.8 Mexico
      • 9.2.8.1 Mexico eubiotics market, 2018 - 2032
      • 9.2.8.2 Mexico eubiotics market, by product, 2018 - 2032
      • 9.2.8.3 Mexico eubiotics market, by form, 2018 - 2032
      • 9.2.8.4 Mexico eubiotics market, by application, 2018 - 2032
      • 9.2.8.5 Mexico eubiotics market, by livestock, 2018 - 2032
  • 9.3 Europe
    • 9.3.1 Europe eubiotics market, 2018 - 2032
    • 9.3.2 Europe eubiotics market, by product, 2018 - 2032
    • 9.3.3 Europe eubiotics market, by form, 2018 - 2032
    • 9.3.4 Europe eubiotics market, by application, 2018 - 2032
    • 9.3.5 Europe eubiotics market, by livestock, 2018 - 2032
    • 9.3.6 UK
      • 9.3.6.1 UK eubiotics market, 2018 - 2032
      • 9.3.6.2 UK eubiotics market, by product, 2018 - 2032
      • 9.3.6.3 UK eubiotics market, by form, 2018 - 2032
      • 9.3.6.4 UK eubiotics market, by application, 2018 - 2032
      • 9.3.6.5 UK eubiotics market, by livestock, 2018 - 2032
    • 9.3.7 Germany
      • 9.3.7.1 Germany eubiotics market, 2018 - 2032
      • 9.3.7.2 Germany eubiotics market, by product, 2018 - 2032
      • 9.3.7.3 Germany eubiotics market, by form, 2018 - 2032
      • 9.3.7.4 Germany eubiotics market, by application, 2018 - 2032
      • 9.3.7.5 Germany eubiotics market, by livestock, 2018 - 2032
    • 9.3.8 France
      • 9.3.8.1 France eubiotics market, 2018 - 2032
      • 9.3.8.2 France eubiotics market, by product, 2018 - 2032
      • 9.3.8.3 France eubiotics market, by form, 2018 - 2032
      • 9.3.8.4 France eubiotics market, by application, 2018 - 2032
      • 9.3.8.5 France eubiotics market, by livestock, 2018 - 2032
    • 9.3.9 Italy
      • 9.3.9.1 Italy eubiotics market, 2018 - 2032
      • 9.3.9.2 Italy eubiotics market, by product, 2018 - 2032
      • 9.3.9.3 Italy eubiotics market, by form, 2018 - 2032
      • 9.3.9.4 Italy eubiotics market, by application, 2018 - 2032
      • 9.3.9.5 Italy eubiotics market, by livestock, 2018 - 2032
    • 9.3.10 Russia
      • 9.3.10.1 Russia eubiotics market, 2018 - 2032
      • 9.3.10.2 Russia eubiotics market, by product, 2018 - 2032
      • 9.3.10.3 Russia eubiotics market, by form, 2018 - 2032
      • 9.3.10.4 Russia eubiotics market, by application, 2018 - 2032
      • 9.3.10.5 Russia eubiotics market, by livestock, 2018 - 2032
    • 9.3.11 Spain
      • 9.3.11.1 Spain eubiotics market, 2018 - 2032
      • 9.3.11.2 Spain eubiotics market, by product, 2018 - 2032
      • 9.3.11.3 Spain eubiotics market, by form, 2018 - 2032
      • 9.3.11.4 Spain eubiotics market, by application, 2018 - 2032
      • 9.3.11.5 Spain eubiotics market, by livestock, 2018 - 2032
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific eubiotics market, 2018 - 2032
    • 9.4.2 Asia Pacific eubiotics market, by product, 2018 - 2032
    • 9.4.3 Asia Pacific eubiotics market, by form, 2018 - 2032
    • 9.4.4 Asia Pacific eubiotics market, by application, 2018 - 2032
    • 9.4.5 Asia Pacific eubiotics market, by livestock, 2018 - 2032
    • 9.4.6 China
      • 9.4.6.1 China eubiotics market, 2018 - 2032
      • 9.4.6.2 China eubiotics market, by product, 2018 - 2032
      • 9.4.6.3 China eubiotics market, by form, 2018 - 2032
      • 9.4.6.4 China eubiotics market, by application, 2018 - 2032
      • 9.4.6.5 China eubiotics market, by livestock, 2018 - 2032
    • 9.4.7 India
      • 9.4.7.1 India eubiotics market, 2018 - 2032
      • 9.4.7.2 India eubiotics market, by product, 2018 - 2032
      • 9.4.7.3 India eubiotics market, by form, 2018 - 2032
      • 9.4.7.4 India eubiotics market, by application, 2018 - 2032
      • 9.4.7.5 India eubiotics market, by livestock, 2018 - 2032
    • 9.4.8 Japan
      • 9.4.8.1 Japan eubiotics market, 2018 - 2032
      • 9.4.8.2 Japan eubiotics market, by product, 2018 - 2032
      • 9.4.8.3 Japan eubiotics market, by form, 2018 - 2032
      • 9.4.8.4 Japan eubiotics market, by application, 2018 - 2032
      • 9.4.8.5 Japan eubiotics market, by livestock, 2018 - 2032
    • 9.4.9 Thailand
      • 9.4.9.1 Thailand eubiotics market, 2018 - 2032
      • 9.4.9.2 Thailand eubiotics market, by product, 2018 - 2032
      • 9.4.9.3 Thailand eubiotics market, by form, 2018 - 2032
      • 9.4.9.4 Thailand eubiotics market, by application, 2018 - 2032
      • 9.4.9.5 Thailand eubiotics market, by livestock, 2018 - 2032
    • 9.4.10 Malaysia
      • 9.4.10.1 Malaysia eubiotics market, 2018 - 2032
      • 9.4.10.2 Malaysia eubiotics market, by product, 2018 - 2032
      • 9.4.10.3 Malaysia eubiotics market, by form, 2018 - 2032
      • 9.4.10.4 Malaysia eubiotics market, by application, 2018 - 2032
      • 9.4.10.5 Malaysia eubiotics market, by livestock, 2018 - 2032
    • 9.4.11 Australia
      • 9.4.11.1 Australia eubiotics market, 2018 - 2032
      • 9.4.11.2 Australia eubiotics market, by product, 2018 - 2032
      • 9.4.11.3 Australia eubiotics market, by form, 2018 - 2032
      • 9.4.11.4 Australia eubiotics market, by application, 2018 - 2032
      • 9.4.11.5 Australia eubiotics market, by livestock, 2018 - 2032
    • 9.4.12 South Korea
      • 9.4.12.1 South Korea eubiotics market, 2018 - 2032
      • 9.4.12.2 South Korea eubiotics market, by product, 2018 - 2032
      • 9.4.12.3 South Korea eubiotics market, by form, 2018 - 2032
      • 9.4.12.4 South Korea eubiotics market, by application, 2018 - 2032
      • 9.4.12.5 South Korea eubiotics market, by livestock, 2018 - 2032
  • 9.5 Latin America (LATAM)
    • 9.5.1 LATAM eubiotics market, 2018 - 2032
    • 9.5.2 LATAM eubiotics market, by product, 2018 - 2032
    • 9.5.3 LATAM eubiotics market, by form, 2018 - 2032
    • 9.5.4 LATAM eubiotics market, by application, 2018 - 2032
    • 9.5.5 LATAM eubiotics market, by livestock, 2018 - 2032
    • 9.5.6 Brazil
      • 9.5.6.1 Brazil eubiotics market, 2018 - 2032
      • 9.5.6.2 Brazil eubiotics market, by product, 2018 - 2032
      • 9.5.6.3 Brazil eubiotics market, by form, 2018 - 2032
      • 9.5.6.4 Brazil eubiotics market, by application, 2018 - 2032
      • 9.5.6.5 Brazil eubiotics market, by livestock, 2018 - 2032
  • 9.6 Middle East & Africa (MEA)
    • 9.6.1 MEA eubiotics market, 2018 - 2032
    • 9.6.2 MEA eubiotics market, by product, 2018 - 2032
    • 9.6.3 MEA eubiotics market, by form, 2018 - 2032
    • 9.6.4 MEA eubiotics market, by application, 2018 - 2032
    • 9.6.5 MEA eubiotics market, by livestock, 2018 - 2032
    • 9.6.6 South Africa
      • 9.6.6.1 South Africa eubiotics market, 2018 - 2032
      • 9.6.6.2 South Africa eubiotics market, by product, 2018 - 2032
      • 9.6.6.3 South Africa eubiotics market, by form, 2018 - 2032
      • 9.6.6.4 South Africa eubiotics market, by application, 2018 - 2032
      • 9.6.6.5 South Africa eubiotics market, by livestock, 2018 - 2032
    • 9.6.7 Saudi Arabia
      • 9.6.7.1 Saudi Arabia eubiotics market, 2018 - 2032
      • 9.6.7.2 Saudi Arabia eubiotics market, by product, 2018 - 2032
      • 9.6.7.3 Saudi Arabia eubiotics market, by form, 2018 - 2032
      • 9.6.7.4 Saudi Arabia eubiotics market, by application, 2018 - 2032
      • 9.6.7.5 Saudi Arabia eubiotics market, by livestock, 2018 - 2032
    • 9.6.8 UAE
      • 9.6.8.1 UAE eubiotics market, 2018 - 2032
      • 9.6.8.2 UAE eubiotics market, by product, 2018 - 2032
      • 9.6.8.3 UAE eubiotics market, by form, 2018 - 2032
      • 9.6.8.4 UAE eubiotics market, by application, 2018 - 2032
      • 9.6.8.5 UAE eubiotics market, by livestock, 2018 - 2032

Chapter 10 Company Profiles

  • 10.1 DSM
    • 10.1.1 Business Overview
    • 10.1.2 Financial Data
    • 10.1.3 Product Landscape
    • 10.1.4 SWOT Analysis
    • 10.1.5 SWOT Analysis
  • 10.2 Novus International
    • 10.2.1 Business Overview
    • 10.2.2 Financial Data
    • 10.2.3 Product Landscape
    • 10.2.4 SWOT Analysis
    • 10.2.5 Strategic Outlook
  • 10.3 BASF SE
    • 10.3.1 Business Overview
    • 10.3.2 Financial Data
    • 10.3.3 Product Landscape
    • 10.3.4 SWOT Analysis
    • 10.3.5 Strategic Outlook
  • 10.4 Beneo GmbH
    • 10.4.1 Business Overview
    • 10.4.2 Financial Data
    • 10.4.3 Product Landscape
    • 10.4.4 SWOT Analysis
  • 10.5 Cargill, Inc.
    • 10.5.1 Business Overview
    • 10.5.2 Financial Data
    • 10.5.3 Product Landscape
    • 10.5.4 SWOT Analysis
    • 10.5.5 Strategic Outlook
  • 10.6 ROQUETTE Freres
    • 10.6.1 Business Overview
    • 10.6.2 Financial Data
    • 10.6.3 Product Landscape
    • 10.6.4 SWOT Analysis
  • 10.7 Novozymes
    • 10.7.1 Business Overview
    • 10.7.2 Financial Data
    • 10.7.3 Product Landscape
    • 10.7.4 SWOT Analysis
    • 10.7.5 Strategic Outlook
  • 10.8 Calpis Co., Ltd.
    • 10.8.1 Business Overview
    • 10.8.2 Financial Data
    • 10.8.3 Product Landscape
    • 10.8.4 SWOT Analysis
  • 10.9 Lesaffre Group
    • 10.9.1 Business Overview
    • 10.9.2 Financial Data
    • 10.9.3 Product Landscape
    • 10.9.4 SWOT Analysis
    • 10.9.5 Strategic Outlook
  • 10.10 Behn Meyer
    • 10.10.1 Business Overview
    • 10.10.2 Financial Data
    • 10.10.3 Product Landscape
    • 10.10.4 SWOT Analysis
  • 10.11 Lallemand, Inc.
    • 10.11.1 Business Overview
    • 10.11.2 Financial Data
    • 10.11.3 Product Landscape
    • 10.11.4 SWOT Analysis
    • 10.11.5 Strategic Outlook
  • 10.12 Friesland Campina
    • 10.12.1 Business Overview
    • 10.12.2 Financial Data
    • 10.12.3 Product Landscape
    • 10.12.4 SWOT Analysis
  • 10.13 Chr. Hansen Holding A/S
    • 10.13.1 Business Overview
    • 10.13.2 Financial Data
    • 10.13.3 Product Landscape
    • 10.13.4 SWOT Analysis
    • 10.13.5 Strategic Outlook
  • 10.14 Neospark
    • 10.14.1 Business Overview
    • 10.14.2 Financial Data
    • 10.14.3 Product Landscape
    • 10.14.4 SWOT Analysis
  • 10.15 Kemin Industries, Inc.
    • 10.15.1 Business Overview
    • 10.15.2 Financial Data
    • 10.15.3 Product Landscape
    • 10.15.4 SWOT Analysis
  • 10.16 BioResource International Inc
    • 10.16.1 Business Overview
    • 10.16.2 Financial Data
    • 10.16.3 Product Landscape
    • 10.16.4 SWOT Analysis
  • 10.17 ABVista
    • 10.17.1 Business Overview
    • 10.17.2 Financial Data
    • 10.17.3 Product Landscape
    • 10.17.4 SWOT Analysis
  • 10.18 Alltech
    • 10.18.1 Business Overview
    • 10.18.2 Financial Data
    • 10.18.3 Product Landscape
    • 10.18.4 SWOT Analysis